Processing....
Lou Von Thaer, president and CEO of Battelle, was presented with his 2020 Wash100 Award by Executive Mosaic for expanding the company’s revenue and influence in the government contracting (GovCon) sector through valuable contract awards, partnerships and important executive appointments. Executive Mosaic congratulates Battelle and Lou Von Thaer f...
Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and Human Services to initially supply 300K doses of bamlanivimab, an investigational monoclonal antibody drug for COVID-19....
ICF (Nasdaq: ICFI) has secured a potential five-year, $49M blanket purchase agreement with an initial $4M task order to help the Food and Drug Administration's enterprise shared service organization modernize and maintain information technology platforms....
The Trump administration has awarded Abbott Laboratories (NYSE: ABT) a potential $760M contract to provide 150M rapid COVID-19 diagnostics tests....
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M doses of its COVID-19 vaccine candidate as part of the U.S. government’s Operation Warp Speed....
Four commercial and nonprofit organizations have won spots on a potential five-year, $90M blanket purchase agreement to conduct social science research for the Food and Drug Administration, FedHealthIT reported Friday....
The Food and Drug Administration is looking to deploy artificial intelligence-based capabilities to support the drug product assessments and business operations....
The General Services Administration and the Food and Drug Administration have partnered to support FDA’s information technology modernization efforts through GSA’s Centers of Excellence initiative....
The National Institutes of Health has launched a new initiative to accelerate the development and commercialization of testing technologies for the new coronavirus. The Rapid Acceleration of Diagnostics program will use $1.5B in federal stimulus funds to invest in efforts that work on new COVID-19 testing technologies, NIH said Thursday....
The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH, European Medicines Agency and 16 biopharmaceutical companies to speed up the development of vaccines and treatments for COVID-19. The Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership will work to streamline c...
